Platelet reactivity, fibrinogen and smoking

Area of Science:

• Cardiovascular Science
• Hematology
• Public Health

Background:

• Smoking is a major risk factor for cardiovascular disease.
• Understanding the impact of smoking on hemostasis is crucial for risk assessment.

Purpose of the Study:

• To investigate the effects of habitual smoking on platelet reactivity and plasma coagulation factors in young healthy males.
• To compare specific hemostatic markers between smokers and non-smokers.

Main Methods:

• Study involved 40 healthy young male volunteers (20 smokers, 20 non-smokers).
• Assessed systolic blood pressure, venous platelet count, ADP-induced platelet aggregation, plasma beta-thromboglobulin, platelet factor 4, serum thromboxane B2, plasma factor VIII:C activity, and plasma fibrinogen.

Main Results:

• Smokers exhibited significantly lower systolic blood pressure and higher venous platelet counts.
• No significant differences were observed in ADP-induced platelet aggregation, beta-thromboglobulin, platelet factor 4, serum thromboxane B2, or factor VIII:C activity.
• Plasma fibrinogen levels were significantly higher in smokers compared to non-smokers.

Conclusions:

• Habitual smoking in young men is associated with elevated plasma fibrinogen levels and increased platelet counts.
• While some hemostatic markers are unaffected, the increase in fibrinogen suggests a prothrombotic state potentially contributing to cardiovascular risk in smokers.